Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Carbonate for Postoperative Sleep and Cognition in Heart Valve Surgery
NCT05593627Phase 4Recruiting
- Sponsor
- China Medical University
- Start
- Jul 2023
- Primary completion
- Dec 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lithium carbonate in Postoperative sleep disturbance (PSD) and Post-operative cognitive dysfunction (POCD), sponsored by China Medical University. Primary endpoint: Sleep quality. Started Jul 2023; status: recruiting.
02
Drugs
lithium carbonate
03
Conditions
Postoperative sleep disturbance (PSD)Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT05593627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05593627.